For HIV-positive individuals in Southeast Asia, baseline CD4 count <350 cells/mm 3 showed a trend toward increased risk of any anal HR-HPV persistence, while antiretroviral therapy use and plasma HIV-RNA had no association with any anal HR-HPV persistence ( 34 ), whereas, in the same region, another investigation revealed that CD4 + count, HIV-RNA, or use of combination antiretroviral therapy were not significantly associated with the prevalence of anal HR-HPV types in HIV-positive MSM.
← all excerpts
Risk factors of oncogenic HPV infection in HIV-positive men with anal condyloma acuminata in Shenzhen, Southeast China: a retrospective cohort study.
1
—
—